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ABSTRACT 
Background: Epileptic syndromes with continuous spikes and waves during sleep (CSWS) represent a 
wide spectrum of epileptic conditions associated with cognitive dysfunctions that have the EEG pattern 
of CSWS as a common feature. Reported are the results of voxel-based analyses of brain glucose 
metabolism performed in a group of 18 children with CSWS.  
Methods: Voxel-based analyses of cerebral glucose metabolism were performed using statistical 
parametric mapping (SPM). First, each patient was compared with a control group and the influence of 
age, epileptic activity, and corticosteroid treatment on metabolic abnormalities was studied. Also, 
disease-related changes in the contribution of a brain area to the level of metabolic activity in another 
brain area were investigated using pathophysiologic interactions in groups of patients compared with 
the control group.  
Results: Individual SPM analyses identified three metabolic patterns: association of hypermetabolic and 
hypometabolic areas, hypometabolic areas only, and normal pattern. Age and intensity of awake 
interictal spiking did not significantly differ in patients showing focal hypermetabolism compared with 
the other ones. Treatment with corticosteroids was associated with absence of focal hypermetabolism. 
In the group of patients with hypermetabolic areas, analyses of pathophysiologic interactions showed 
disease-related altered functional connectivity between the parietal and frontal cortices.  
Conclusions: Cerebral metabolic patterns are heterogeneous among patients with CSWS. This metabolic 
heterogeneity could be related to the use of corticosteroid treatment before PET. The parietofrontal 
altered connectivity observed in patients with hypermetabolism is interpreted as a phenomenon of 
 
remote inhibition of the frontal lobes induced by highly epileptogenic and hypermetabolic posterior 
cortex. 
Epileptic syndromes with continuous spikes and waves during slow sleep (CSWS) represent a wide 
spectrum of epileptic conditions associated with various cognitive dysfunctions that have the EEG pat-
tern of CSWS as a common feature.1 This EEG pattern is defined by the presence of spike and wave 
discharges during at least 85% of non-REM (NREM) sleep.1-2 The cognitive deficits associated with CSWS 
include auditive agnosia or Landau-Kleffner syndrome (LKS),3 dysfunctions of the frontal lobe,4-5 
pseudo-bulbar palsy,6,7 global mental deterioration,8 apraxia and heminegligence,8 psychotic states,1 
and visual agnosia.9 
Several PET studies with [18F]fluorodeoxyglucose (FDG) have been performed in epileptic syndromes 
with CSWS and have identified focal cerebral abnormalities in most patients.6-8-10-11 However, results of 
these studies are heterogeneous. Indeed, some authors found a predominance of focal or multifocal 
hypermetabolism,6,8 whereas others found a predominance of focal or multifocal hypometabolism.7,10 
These metabolic changes predominantly involved associative cortices and were, in most cases, 
anatomically related with the EEG foci and with the type of neuropsychological deterioration 
observed.6,8,10,11 
To better determine factors that might cause either hypermetabolic or hypometabolic areas to be 
associated with CSWS, we specifically studied the influence of age, epileptic activity when awake, and 
corticosteroid treatment on metabolic abnormalities found in a large population of epileptic children 
with the EEG pattern of CSWS. PET data were analyzed using a voxel-based method, statistical 
parametric mapping (SPM). This method provided a way to characterize metabolic patterns in single 
individuals as well as groups of patients. It also offers the opportunity to study functional connectivity 
between brain areas showing metabolic dysfunctions. 
Methods 
PATIENTS AND CONTROL SUBJECTS.  
Among the population of patients studied by FDG-PET in the context of a presurgical evaluation for focal 
epilepsy between January 1996 and January 2003 at the PET/Biomedical Cyclotron Unit of Erasme 
Hospital, a group of 18 children was retrospectively selected based on the following criteria: 1) age 
above 5 years, 2) presence of >85% of spikes and waves during NREM sleep on an EEG recorded within 
7 days before PET, 3) absence of structural lesion on cerebral MRI, 4) absence of suspected genetic or 
chromosomic syndrome, and 5) focal EEG abnormalities. Patients with only generalized epileptiform 
abnormalities were excluded because our PET methodology did not include quantification of regional 
cerebral glucose metabolism precluding the identification of global metabolic changes. 
The patients, 13 boys and 5 girls (sex ratio: 2.6), aged 5 to 11 years, were referred from different centers 
in Belgium and France. All of them underwent neurologic examination, neuropsychological evaluation 
adapted to the patient’s age and collaboration, cerebral MRI, and awake and sleep scalp EEG using 21 
electrodes placed according to the 10-20 International System. Ictal events were recorded in only a few 
patients because most patients had rare seizures or no clinical seizures at all. According to the 
neurologic and neuropsychological abnormalities, five syndromes classified the patients: 1) frontal 
syndrome,4,5 six patients; 2) LKS,3 five patients; 3) global mental deterioration,8 four patients; 4) left 
 
apraxia and heminegligence syndrome,8 two patients; and 5) opercular syndrome,7 one patient. The 
clinical data of each patient are summarized in table E-1 in the supplementary material on the 
Neurology Web site (go to www.neurology.org). 
A group of 26 healthy volunteers, 10 men and 16 women, aged 18 to 42 years (mean age 28 years), was 
used as control population. The Ethics Committee of ULB-Erasme Hospital gave approval for this group 
examination. Written informed consent was obtained from all control subjects. 
PET IMAGING.  
PET scans were obtained using a CTI-Siemens ECAT 962 (HR+) tomograph (Erlangen, Germany), the 
characteristics of which have been previously described.12 All patients were awake at the time of FDG 
injection, fasted for at least 4 hours, and received an IV bolus injection of 2 to 3 mCi (74 to 111 MBq) of 
FDG before PET acquisition in three-dimensional mode. Patients were not sedated for PET data 
acquisition. The current antiepileptic treatment was unchanged. EEG was monitored during each PET 
procedure. All patients were seizure-free for at least 72 hours. 
PET DATA ANALYSES. 
SPM analyses were performed on a SPARC workstation (Sun Microsystems, Surrey, UK) using SPM99 
software (Wellcome Department of Cognitive Neurology, London, UK) implemented in MATLAB 
(Mathworks, Sherborn, MA). The PET images were spatially normalized into the standard Talairach 
space using a template provided by the Montreal Neurologic Institute (Quebec, Canada). The scans were 
then smoothed using a 16-mm full width at half-maximum isotropic kernel. Global activity 
normalization was performed by proportional scaling. 
Individual analyses compared each individual patient with the control group.13-15 The design matrix 
included the patient’s scan and the scans of the 26 control subjects. For each patient, separate analysis 
identified brain regions where glucose metabolism was significantly lower or higher than in the control 
population. The resulting set of voxel values for each contrast constituting a map of t statistics, SPM(T), 
was transformed in a normal distribution, SPM(Z), and thresholded at p < 0.001 (Z = 3.09). 
Patients were classified into two groups based on the presence (Group 1) or the absence (Group 2) of at 
least one significant hypermetabolic brain area in individual SPM analyses. Differences in metabolic 
abnormalities between these two groups were assessed by exclusive masking analysis of comparisons 
with the control group. 
We also searched for factors that could influence the metabolic pattern. Unpaired t-test was used to 
search for differences in age between the two groups of patients. The influence of epileptic activity on 
cerebral glucose metabolism was assessed by counting the number of spikes occurring in each epileptic 
focus within the 15-minute period after FDG injection, the patient being awake. This allowed 
determining a spike index (number of spikes per minute) for each epileptic focus. Unpaired t-test was 
used to search for differences between the spike index of epileptic foci anatomically related to 
hypermetabolic areas and those related to normometabolic or hypometabolic areas. 
We also searched for an association between hypermetabolism in individual metabolic patterns and 
use of corticosteroid treatment before PET using the Fisher exact test. 
Finally, based on the results of group analyses, we elaborated an a priori hypothesis of altered 
functional connectivity between hyper- and hypometabolic brain areas. To test this hypothesis, we 
 
searched for “pathophysiologic interactions” between these brain areas in groups of patients compared 
with the control group. Pathophysiologic interactions are here defined as disease-related changes in 
the contribution of a brain area to the level of metabolic activity in another brain area. As such, this 
analysis is an application to pathologic conditions of the psychophysiologic interaction analysis 
developed previously.16 More specifically, the pathophysiologic interaction analyses here conducted 
searched for disease-related differences in modulation between a hypermetabolic brain area and the 
rest of the brain in groups of patients compared with the control group. For pathophysiologic 
interaction analyses, we selected the peak voxel value in the considered hypermetabolic area, which 
was used as a covariate centered around condition means and interacting with each condition. 
All results of subtractive SPM analyses were considered significant at p < 0.05 corrected for multiple 
comparisons over the entire brain volume for the voxel level and the cluster level. Exclusive masking 
analyses were performed using an uncorrected mask p value and a height threshold at 0.001. For 
connectivity studies, as we had an a priori hypothesis concerning the brain areas presenting altered 
functional connectivity with the considered hyper- metabolic area, results were considered significant 
at small volume-corrected p < 0.05 using a 20-mm radius spherical volume of interest on our 
predetermined regions. For unpaired t-test and Fisher exact tests, the significance level was set at p < 
0.05. 
As brain metabolism of children aged 5 to 11 years was compared with that of a population of young 
adults, regional cerebral metabolic changes that could be attributed to physiologic age- related 
changes (i.e., thalami and anterior cingulate cortices) were not considered in Results.17 
Results.  
INDIVIDUAL PATTERNS OF CEREBRAL METABOLISM.  
The individual patterns of region cerebral glucose metabolism are summarized in table E-1 on the 
Neurology Web site. Three metabolic patterns were found: hypermetabolic areas associated with 
distinct hypometabolic areas (10 patients), hypo- metabolic areas only (5 patients), and absence of any 
significant metabolic abnormality (3 patients). Metabolic patterns among patients exhibiting the same 
neuropsychological profile were heterogeneous (see table E-1 on the Neurology Web site). 
Hypermetabolic cerebral regions were associated with an EEG focus in all patients. By contrast, there 
was no strong anatomic association between hypometabolic areas and EEG foci in most of the 15 
patients presenting at least one hypometabolic area. We did not find significant differences in spike 
index between epileptic foci anatomically related with hypermetabolic areas and those related to 
normometabolic or hypometabolic areas (p = 0.6). The number of spikes per minute for each epileptic 
focus is shown in table E-1 on the Neurology Web site. 
Based on individual metabolic patterns, patients were divided into two groups according to the 
presence (Group 1, 10 patients) or the absence (Group 2, 8 patients) of at least one significant 
hypermetabolic area. These groups did not differ for age (p = 0.19). 
Six of the 18 patients had received steroids before PET. Patient 10 had received a 5-month 
hydrocortisone course, which was stopped 3 months before PET. At the time of PET, Patient 4 had been 
treated by hydrocortisone for 6 years, Patient 6 for 2 years, and Patient 15 for 11 months and Patient 5 
by prednisone for 2 months. Patient 14 had received prednisolone for 3 months; this treatment was 
 
interrupted 15 days before PET. Overall, among the 10 patients included in Group 1, only 1 had received 
corticosteroids before PET vs 5 of the 8 patients included in Group 2. The association between the 
absence of hyper- metabolic abnormalities and the use of steroids before PET evaluation was significant 
(p < 0.05). 
Figure 1. The comparison of Group 1 with the control group using exclusive masking by Group 2 statistical parametric 
mapping analyses shows a hypermetabolic area involving the right postcentral gyrus and the right parietotemporal 
junction (left) and hypometabolism in the frontal lobes (right). This figure illustrates the metabolic abnormalities 
found in Group 1 and not in Group 2. 
 
GROUP ANALYSES.  
Differences between metabolic abnormalities found in Group 1 and Group 2 were assessed by exclusive 
masking analyses of comparisons with the control group. In Group 1, these analyses localized a 
common hypermetabolic area involving the right postcentral gyrus and the right parietotemporal 
junction (cluster-level pcorrected = 0.001, cluster size: 2,301, voxel-level pcorrected = 0.034, Zscore = 4.3, 
coordinates: [64, —16, 18]), which was not present in Group 2 (figure 1). These analyses also showed the 
presence of a large hypometabolic area including the superior and medial frontal gyri and the right 
inferior frontal gyrus in Group 1 but not in Group 2 (see figure 1). In Group 2, exclusive masking using 
Group 1 SPM analyses did not reveal any significant differences. 
Pathophysiologic interaction studies were conducted on the basis of these group analyses to better 
understand the relationships between brain areas that exhibited metabolic abnormalities. Right 
parietal hypermetabolism and bilateral frontal hypometabolism were found to be specific to Group 1. 
Altered modulation between these regions was therefore hypothesized in this group, and 
pathophysiologic interaction studies were performed to test this a priori hypothesis. When considering 
the peak voxel value in the right postcentral gyrus (64, —16, 18), significant modifications in interactions 
with the cerebral glucose metabolism in the left superior frontal gyrus (—16, 56, 36; —16, 58, 32) were 
found in Group 1 compared with the control group (figure 2; see also table E-2 on the Neurology Web 
site). These frontal voxels were included in the large hypometabolic area involving the lateral frontal 
cortex in patients of Group 1. No significant change in interaction between the above considered brain 
areas was found in Group 2 compared with the control group. 
Discussion 
Voxel-based analyses of cerebral glucose metabolism in a population of 18 patients presenting the EEG 
pattern of CSWS led to the following original findings: 1) A group of patients presents hypermetabolic 
cerebral areas that are related to epileptic foci and are associated with distinct hypometabolic areas; 2) 





Figure 2. Regression plot of metabolic activity in the right postcentral gyrus and the left superior frontal gyrus in 
Group 1 (red crosses), Group 2 (blue diamonds), and control subjects (green circles). This plot illustrates the disease-
related changes in the contribution of the right parietal lobe to the level of metabolic activity in the left frontal lobe 
observed in the group of patient with hypermetabolic areas (Group 1) compared with the control group. The group of 
patients without hypermetabolic area (Group 2) does not differ from control subjects. 
 
 
Spatial normalization may fail for brains of small size when using an adult template.18 However, this risk 
is negligible for the population studied here. Indeed, the brain volume does not change substantially 
from age 5 to adulthood.18 This assumption has been confirmed by a study that specifically addressed 
this question in children above age 6.19 
Individual analyses identified three types of metabolic patterns: the association of hypermetabolic and 
hypometabolic areas (10 patients), the presence of one or multiple areas of hypometabolism (5 pa-
tients), and the absence of significant abnormality (3 patients). We did not find any specific metabolic 
pattern characterizing the different types of epileptic syndromes considered in this study. Indeed, the 
maps of cortical metabolic changes were heterogeneous among patients exhibiting the same type of 
neuropsychological profile. It was previously suggested that temporal lobe dysfunctions were 
important in the pathophysiology of LKS.10 We found that temporal lobe dysfunction was not specific to 
this syndrome. The results obtained in this study suggest that altered glucose metabolism of specific 
cerebral areas is not the key to the neuropsychological differentiation among different epileptic 
syndromes with CSWS. Dissociation between cognitive deficit and dysfunction in related neuronal 
networks has been repeatedly observed in functional neuroimaging studies. This phenomenon raises 
the question of which brain area is necessarily required to support a specific function.20 Cerebral 
activation studies using specific paradigms could explore these aspects.20 
Focal hypermetabolism was found in 10 patients. This type of metabolic abnormality has already been 
reported in other cases of epilepsy with CSWS and is likely to reflect intense epileptic activity.6,8,11 This is 
supported by the fact that, in the current study, areas of hypermetabolism were anatomically related 
to the epileptic foci in all patients. Local rise in glucose consumption as a sign of high neuronal activity 
 
induced by interictal spiking has been shown in animal models of epilepsy,21 but enhanced inhibition 
could also contribute to the increased glucose metabolism in this situation.22 In eight patients, we did 
not find any significant hypermetabolic area. In these patients, the neuronal activity associated with 
interictal spiking was probably not intense enough to be associated with substantial rise in glucose 
consumption. As PET studies were performed during wakefulness, the hypothesis can be raised of a 
relationship between focal interictal spiking activity and glucose metabolism in anatomically related 
brain areas. Yet, spike indexes were not statistically different in epileptic foci associated or not with 
hypermetabolic areas. Still, the simple count of spikes recorded on scalp EEG may not be a good marker 
of the synaptic activity associated with an epileptic focus. Other parameters like the power of the 
electrical dipole or the importance of the GABAergic inhibition need to be considered in further studies. 
Presence or absence of focal hypermetabolism may also reflect different stages of the disease. This 
hypothesis is supported by a previous study that showed that hypermetabolism during the acute phase 
of the epileptic disease may evolve to hypometabolism or normal metabolic pattern during the recovery 
phase.8 Preliminary data on the follow-up of some patients studied in the current work confirm these 
findings.23 We did not find any age difference between patients with and without hypermetabolism. We 
found, however, a significant association between the absence of hypermetabolic cerebral area and 
corticosteroid treatment before PET. The metabolic heterogeneity found in this population could 
therefore be related, in part, to this treatment. A direct effect of steroids on cerebral glucose metabolism 
needs to be considered. Indeed, several studies have shown that steroids reduce global cerebral glucose 
metabolism and cerebral blood flow and to a greater extent hippocampal metabolism.24-26 The existence 
of a steroid-induced reduction of cerebral glucose metabolism is further supported by the increased 
glucose utilization throughout the brain observed in adrenalectomized rats.27 However, our SPM 
method included normalization for the global cerebral activity, which allowed detection of focal 
metabolic changes only. Moreover, focal mesiotemporal metabolic abnormalities were not observed in 
any of our patients. Therefore, other mechanisms than a direct action of corticosteroids on cerebral 
glucose metabolism should be considered to explain our results. 
These mechanisms could be an acceleration of brain maturation or a modulation of various 
neurotransmitter systems involved in epilepsy.28 Corticosteroids are the treatment of choice of epileptic 
syndromes with CSWS, having favorable and long-lasting effects on CSWS and neuropsychological 
deficits in most cases.29,30 Therefore, it could be hypothesized that the absence of hypermetabolism in 
some patients previously treated by corticosteroids might reflect an evolution toward the recovery 
phase of the disease. 
Hypometabolic areas were found in 15 of 18 patients. Several hypotheses may be raised to explain this 
regional hypometabolism. It could relate to cerebral lesions not visible on MRI. This hypothesis is 
unlikely as results of longitudinal studies have shown a trend to normalization of the hyper- and 
hypometabolic abnormalities with the resolution of the epileptic disorder.8,23 Another hypothesis to 
consider is a phenomenon of “postictal depression” induced by electrical status epilepticus occurring 
during slow-wave sleep. This mechanism could explain why other authors found metabolic differences 
between scans performed during wakefulness and sleep in the same patient.8,11 Such a mechanism can-
not be excluded in our population as patients were studied only during wakefulness. A third hypothesis 
is that hypometabolic areas could be induced by surrounding inhibition. Surrounding inhibition is 
defined as a strong inhibition of neurons surrounding a group of neurons that display epileptiform dis-
charges and is viewed as a mechanism of protection from seizure propagation.31 This hypothesis is 
 
supported by PET studies performed in children with refractory epilepsy showing reduction of glucose 
metabolism measured in the interictal state in the cortex surrounding an isometabolic epileptogenic 
area.32 
To better understand the relationship between brain areas that exhibit metabolic abnormalities, we 
searched for disease-related changes in the functional connectivity between these brain areas. Group 
analyses showed that the metabolic pattern that actually characterized patients with hypermetabolic 
areas (Group 1) was an association of right parietal hypermetabolism and bilateral frontal 
hypometabolism. Pathophysiologic interactions were then used to search for disease-related changes 
in the contribution of the right parietal lobe to the level of metabolic activity in the frontal lobes.16 When 
searching for significant differences in modulation between the peak voxel value of the right parietal 
hypermetabolic area and the rest of the brain, altered interactions between this brain area and the left 
frontal lobe were found in patients with hypermetabolic areas (Group 1). We did not find altered 
modulation between the right parietal lobe and the ipsilateral frontal lobe. This is somewhat surprising 
as one would expect that ipsilateral frontoparietal connectivity is stronger than those between 
contralateral areas. This discrepancy is probably due to metabolic heterogeneity in terms of 
lateralization of hypermetabolic areas. In particular, individual analyses revealed hypermetabolic 
areas, which were bilateral in six patients, left-sided in one, and right-sided in three. In our opinion, a 
mechanism of “remote inhibition” would best explain our findings. We here define “remote inhibition” 
as a strong inhibition of distant brain areas induced by the epileptic focus. This phenomenon has been 
well documented in animal models of epilepsy.31 In particular, parietal hypermetabolism associated 
with frontal hypometabolism has been observed in rats after injection of penicillin in the primary 
somatosensory cortex, which induced acute epileptic activity at the site of injection.33 The occurrence 
of such a mechanism in human epilepsies has been previously suspected in patients with hippocampal 
sclerosis. In an ictal SPECT study performed in patients with mesiotemporal lobe epilepsy, unilateral 
hippocampal hyperperfusion was associated with transient hypoperfusion in both frontal lobes.34 
Remote inhibition could also explain the presence of extratemporal (frontal or thalamic) interictal 
dysfunction in patients with temporal lobe epilepsy.14-35-36 Indeed, distant regional hypometabolism 
may be reversible after the surgical cure of epilepsy.37 Remote functional inhibition may be related to 
either direct intracortical connections from the epileptic focus to the hypometabolic area or 
polysynaptic pathways involving subcortical structures.33-38 In our population, both types of connection 
between the parietal and frontal lobes may be considered in view of the existence of numerous 
projections from the parietal lobes to the ipsilateral and contralateral frontal lobes. These anatomic 
links are corticocortical or polysynaptic via subcortical structures.39 Taken together, these data support 
the possible existence of frontal lobe inhibition induced by more posterior epileptic brain regions. 
From a clinical point of view, decreased metabolic activity in the frontal lobes could explain some 
characteristic neuropsychological features observed in children with the EEG pattern of CSWS, such as 
attention deficit disorder or executive dysfunctions. 
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